DOI QR코드

DOI QR Code

Screening of Genes Expressed In Vivo During Interaction Between Chicken and Campylobacter jejuni

  • Hu, Yuanqing (Jiangsu Key Laboratory of Zoonosis, Yangzhou University) ;
  • Huang, Jinlin (Jiangsu Key Laboratory of Zoonosis, Yangzhou University) ;
  • Jiao, Xin-An (Jiangsu Key Laboratory of Zoonosis, Yangzhou University)
  • Received : 2013.08.31
  • Accepted : 2013.11.08
  • Published : 2014.02.28

Abstract

Chicken are considered as the most important source of human infection by Campylobacter jejuni, which primarily arises from contaminated poultry meats. However, the genes expressed in vivo of the interaction between chicken and C. jejuni have not been screened. In this regard, in vivo-induced antigen technology (IVIAT) was applied to identify expressed genes in vivo during interaction between chicken and C. jejuni, a prevalent foodborne pathogen worldwide. Chicken sera were obtained by inoculating C. jejuni NCTC 11168 into Leghorn chickens through oral and intramuscular administration. Pooled chicken sera, adsorbed against in vitro-grown cultures of C. jejuni, were used to screen the inducible expression library of genomic proteins from sequenced C. jejuni NCTC 11168. Finally, 28 unique genes expressed in vivo were successfully identified after secondary and tertiary screenings with IVIAT. The genes were implicated in metabolism, molecular biosynthesis, genetic information processing, transport, regulation and other processes, in addition to Cj0092, with unknown function. Several potential virulence-associated genes were found to be expressed in vivo, including chuA, flgS, cheA, rplA, and Cj0190c. We selected four genes with different functions to compare their expression levels in vivo and in vitro using real-time RT-PCR. The results indicated that these selected genes were significantly upregulated in vivo but not in vitro. In short, the expressed genes in vivo may act as potential virulence-associated genes, the protein encoded by which may be meaningful vaccine candidate antigens for campylobacteriosis. IVIAT provides an important and efficient strategy for understanding the interaction mechanisms between Campylobacter and hosts.

Keywords

Introduction

Campylobacter jejuni is a thermotolerant and microaerophilic spiral, gram-negative bacterium [26] and has emerged as the leading cause of human bacterial foodborne diarrheal disease worldwide. Children are especially susceptible to C. jejuni both in developed and developing countries [39,41]. C. jejuni can colonize in the intestine of chicken and wild birds. The Guillain-Barré syndrome (GBS) is an acute polyneuropathy [18,26] with a global incidence of 0.6-4 cases per 100,000 people. This disease generally occurs after infection by C. jejuni from contaminated food or water [1,34,35,39]. Evidence suggests that GBS results from molecular mimicry between GM1 and GD1a gangliosides and the lipooligosaccharides (LOS) of C. jejuni [4,27]. There is very great pressure to control human campylobacteriosis owing to the broad consumption of contaminated poultry meat products. To prevent chicken products contamination from C. jejuni, a better understanding of the biological characteristics of this pathogen, particularly the interaction mechanisms with hosts, is needed [4].

C. jejuni strain NCTC 11168 has become a widely used laboratory model for studying Campylobacter pathogenicity [5], and its genome sequence was annotated in 2000 [26]. Unlike other diarrhea-causing bacteria, C. jejuni does not express many classical virulence factors, such as pilus structures [26,41]. However, C. jejuni contains O- and N-linked glycosylation systems. It is worth mentioning that interactions between host and pathogen possibly play an important role in Campylobacter pathogenicity [26,41].

In vivo-induced antigen technology (IVIAT) is a novel screening technique that identifies virulence-associated factors during host infection by pathogens [10,29]. Using IVIAT, we can identify pathogenicity-related genes, which are expressed in vivo when a strong interaction occurs between the host and the microbe; however, some factors without immunogenicity are not detected [11,29]. Screening can be performed using IVIAT without an ideal animal model for infection. Thus, this method is well suited for identifying virulence genes from C. jejuni [30]. The adsorption of convalescent sera during the application of IVIAT is very important when using a pathogen grown in the laboratory culture environment. If this step is conducted incompletely, false-positive clones can occur [21,29]. To date, IVIAT has been used for a number of pathogens, including Escherichia coli [19,21], Vibrio [11,42], Streptococcus [9,31,40], Salmonella [12,15,23], Mycobacterium [6,33], Brucella [24], and Bacillus anthracis [30].

In this study, a genomic expression library was constructed using sequenced C. jejuni NCTC 11168, and in vivo-induced antigens were identified from chicken inoculation antisera after being thoroughly adsorbed by cultures of C. jejuni in vitro. These screen of genes expressed in vivo may contribute to understanding the interaction between hosts and microbes, and several antigens are candidate vaccine sites and diagnostic markers.

 

Materials and Methods

Bacteria and Culture Conditions

C. jejuni NCTC 11168 was originally isolated from a clinical patient in the United Kingdom. This strain was cultured on Campy-blood free selective medium (CCDA) (Oxoid Ltd., Basingtoke, UK) plates at 42℃ under microaerobic conditions for 30 h. E. coli DH5α and BL21 (DE3) cells were used as cloning and expression host strains, respectively, to generate the genomic expression library. These strains were inoculated in LB medium and cultivated at 37℃ overnight. The BL21 (DE3) cells containing recombinant plasmids were plated on LB medium plus 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and kanamycin (kan) (50 μg/ml) and incubated at 30℃ for library expression. For determining the protein expression profiles of in vivo-induced genes, the C. jejuni NCTC 11168 strain was cultured on CCDA medium plus 0.1% sodium deoxycholate (DOC; Sigma, USA) [25] (referred to as DOC plates).

Recombinant Expressed Proteins

Proteins FlaA370 and CjaA were constructed and expressed in our laboratory. FlaA370 corresponds to the N-terminal 370 aa of FlaA, and its corresponding gene was inserted into the plasmid pET30a. CjaA was encoded from the complete cjaA gene, which was inserted into the pET30a plasmid. These two recombinant proteins were expressed and purified using affinity chromatography with a His Bind Purification kit (Novagen, Germany). The flagella of C. jejuni NCTC 11168 were extracted and purified according to Ibrahim et al. [17]. Aliquots of the proteins were stored at -80℃.

Library Construction

To construct the genomic expression library of C. jejuni strain NCTC 11168, its genomic DNA was extracted (DNeasy Blood Tissue Kit; Qiagen, Germany) and then partially and randomly digested by Sau3A 1 (Promega, USA). These fragments, ranging from 0.4-3 kb, were then purified (Agarose Gel DNA Purification Kit ver. 2.0; TaKaRa, China) on a 0.9% agarose gel and separately ligated into pET30a, pET30b, and pET30c vectors, which had been digested by BamHI 1 and dephosphorylated by alkaline phosphatase (Shrimp) (TaKaRa). The plasmids were then transformed into competent E. coli DH5α cells. After being cultured at 37℃ overnight, the recombinant plasmids were extracted (MiniBest Plasmid Purification Kit ver. 2.0; Takara) and purified from E. coli DH5α. Aliquots of the plasmids were stored at -80℃ for transforming into the BL21 (DE3) expression host strain.

Preparation of Antisera

The chicken sera were obtained by inoculating C. jejuni NCTC 11168 into Leghorn chickens through oral and intramuscular administration, respectively. Prior to challenge, all the chickens were negative for C. jejuni-specific antibodies, as determined by an indirect ELISA test. Leghorn chickens (n = 14, 50 days old) were randomly grouped into two units (7/unit, named as groups 1 and 2). These chickens were challenged with 2 ml of strain NCTC 11168, intramuscularly for group 1 (4 × 109 CFU), and orally for group 2 (3 × 108 CFU), respectively. All animal experiments were conducted in accordance with national guidelines and were approved by the office of laboratory animal, Yangzhou University and Jiangsu administration committee of laboratory animals. The levels of the total antibodies of chicken were determined with indirect ELISA methods (developed by our laboratory). Chicken individual sera were combined in equal volume and adsorbed using C. jejuni NCTC 11168 whole cells cultured on CCDA plates on a rocking platform (Incubator Shaker; Crystal, China) at 4℃ for 1 h. The sera were adsorbed with C. jejuni whole cells, E. coli BL21 (DE3) whole cells, ultrasonic lysis of C. jejuni or E. coli BL21 (DE3) cells, inactivated ultrasonic lysis supernatants of NCTC 11168 or BL21 (DE3) cells, secreted protein from NCTC 11168, and lysisinduced BL21 (DE3) cells. Indirect ELISAs were conducted for assessing the adsorption of sera by coating C. jejuni NCTC 11168 and E. coli BL21 (DE3) whole cells, lysates, CjaA, FlaA370 recombinant protein, and extracted flagellum protein. Dot-ELISA was conducted according to the standard protocol for assessing the reactivities of antibodies with C. jejuni whole-cell lysis.

In Vivo-Induced Antigen Screening

The IVIAT screening was performed based on previously described methods [11,21,29] with a few modifications. An aliquot of library was transformed into E. coli BL21 (DE3) cells containing 50 μg/ml kan, and incubated at 37℃ overnight. Library colonies were lifted onto sterile NC membranes, and incubated on kan/LB plates for 5 h at 37℃. These membranes with lifted colonies (colony side up) were overlaid on fresh kan/LB plates containing 1 mM IPTG, and incubated for 5 h at 30℃ to induce expression of the cloned inserts. The NC membranes were removed, and were exposed in chloroform vapors for 15 min in a hermetic container. The membranes were blocked with 1% BSA and allowed to incubate for 1 h at room temperature. The membranes were washed three times in PBS plus 0.1% Tween-20 (PBST) for 30 min with gentle agitation at room temperature. Next, the membranes were incubated with 1:1,000 (v/v) dilution of adsorbed sera. Positive colonies were detected using goat anti-chicken-horseradish peroxidase (HRP) secondary antibodies and were visualized using a chemiluminescent ECL substrate (Thermo, USA). Positive clones identified during the primary screening were chosen from the master plates and subjected to secondary screening by patching in an alternating pattern with the BL21 (DE3) vector control. Plasmids from positive clones were subjected to DNA sequencing using pET30-specific primers.

Functional Prediction of the Antigens Identified by IVIAT

The sequences of the in vivo-induced genes were analyzed by BLASTx alignment analysis and a Conserved Domain Database (CDD) domain search (http://www.ncbi.nlm.nih.gov/BLAST/). The subcellular localization of the putative IVIAT-identified proteins was predicted using PSORTb ver. 2.0.4 (http://www.psort.org). Functional classification was based on published studies of identified proteins in C. jejuni NCTC 11168 [26]. When no published functional information for C. jejuni was available, protein functional classification was based on predictive models using the Clusters of Orthologous Groups database (http://www.ncbi.nlm.nih.gov/COG/) or the Pfam database (http://www.sanger.ac.uk.Software/Pfam).

Gene Expression Analysis by Quantitative Real-Time PCR

Gene expression profiles were tested by comparing the RNA transcription on DOC and CCDA plates with the expression of virulence induced with sodium deoxycholate [16,25]. Total RNA was isolated using an RNAprep bacterial kit (TaKaRa) according to the manufacturer’s instructions after a 15-h culture of strain NCTC 11168 on CCDA or DOC plates. The cDNA was synthesized using a RT-PCR kit (TaKaRa) according to the manufacturer’s instructions with 500 ng of RNA. Real-time RT-PCR amplification of 2.0 μl of cDNA was performed using a reaction mixture containing SYBR Premix Ex Taq II (TaKaRa), 10 μM forward primer, 10 μM reverse primer, and diethyl pyrocarbonate-treated water. The real-time RT-PCR analysis was performed using a Gene Amp 7500 thermocycler (Applied Biosystems, CA, USA) with the following PCR parameters: 2 min at 50℃, followed by 40 cycles of denaturation at 95℃ for 30 sec and annealing at 60℃ for 34 sec. Four IVI genes (primers are shown in Table 1) were selected, and their transcription levels in the NCTC 11168 strain cultured on DOC plates were compared with those on CCDA plates. Gene Cj0402 was used to normalize these samples because this housekeeping gene is expressed both on DOC and CCDA plates [25]. Duplicate reactions were performed, and three biological replicates were used for each sample. Threshold cycle values were determined using 7500 software ver. 2.0.1 (Applied Biosystems).

Table 1.Primers used for real-time RT-PCR analysis.

Western-Blotting for Expression and Reaction of IVI Genes

To confirm the immunoreactivity of the IVI proteins, 11 partial genes from recombinant plasmids of the NCTC 11168 genetic expression library were induced to express as His-tagged fusion proteins. The expression of 11 proteins in E. coli BL21(DE3) was induced with 1 mM IPTG at 37℃. Immune responses to these proteins in completely adsorbed chicken serum samples were evaluated using western blotting. In this study, serum was used at a 1:1,000 dilution. The immune responses to peroxidase-conjugated goat anti-chicken IgG at a dilution of 1:1,500 and a chemiluminescent ECL substrate (Thermo) were used for detection.

 

Results

Serum Selection and Adsorption

The higher titer sera (≥1:15,000) were collected and pooled from 14 individual chickens for screening the genomic expression library. The sera were detected after each adsorption process by indirect ELISA plates coated with C. jejuni NCTC 11168 and E. coli BL21 (DE3) whole cells, lysates, CjaA, FlaA370 recombinant protein, and extracted flagellum protein (Fig. 1). The immunoreactivity of the pooled sera with in vitro-grown C. jejuni antigen decreased progressively with a series of adsorption, and the immunoreactivity dropped clearly after the first adsorption step. Dot-ELISA results showed that unadsorbed chicken sera strongly reacted with C. jejuni whole-cell antigens. There were no spots on the NC membrane because the sera had been thoroughly adsorbed using in vitro antigens (Fig. 2). These data indicated that antibodies specific to in vitro antigens had been completely eliminated from the chicken sera set.

Fig. 1.Results of ELISA for chicken sera with seven coated antigens after each adsorption step. The whole cells of C. jejuni NCTC 11168, whole cells of E. coli BL(DE3), lysates from C. jejuni, lysates from BL21(DE3), recombinant CjaA, FlaA370 protein, and extracted flagellum protein were used as coating antigens for assaying the adsorption of sera.

Fig. 2.Dot-ELISA results of reactivities of pooled unadsorbed (A) and adsorbed (B) chicken sera against C. jejuni whole-cell lysates. The proteins of C. jejuni whole-cell lysates were quantified using UV spectrophotometry and diluted to 5 μg to 1 μg for each colony.

Identification of C. jejuni Antigens by IVIAT

The C. jejuni NCTC 11168 library in E. coli, represented by a total of approximately 52,700 clones, was screened using extensively adsorbed, pooled immune chicken serum. Indeed, 207 immunoreactive clones were identified after primary screening. Of the initial clones, 56 were robustly positive upon secondary screening. Finally, 28 unique protein-expressing clones that continuously showed a strong positive reaction with the adsorbed sera antibodies were ascertained by nucleotide sequencing and homology analysis. These 28 proteins have a defined or suspected role during interaction between chicken and C. jejuni. These proteins are implicated in metabolism, molecular biosynthesis, genetic information processing, transport, and regulation (Table 2).

Table 2.Twenty-eight genes identified by IVIAT in C. jejuni from chicken host.

Analysis of the In Vivo Gene Expression Profiles

To evaluate the in vivo expression of C. jejuni genes identified using the IVIAT method, we selected four genes according to their functional category to compare the expression levels in vivo and in vitro using real-time RTPCR. An in vitro DOC plate culturing method was used for analyzing the RNA transcription, mimicking in vivo conditions. The real-time PCR results showed that these four genes were drastically upregulated under in vivo-like conditions (>1-fold), while the other five genes were not (Fig. 3).

Fig. 3.In vivo gene expression relative to the level of expression in vitro by real-time PCR. C. jejuni NCTC 11168 was cultured in plates of CCDA (control in vitro) and DOC (in vivo-like condition) for 15 h, and the transcription levels of mRNA were assessed by real-time PCR. The levels of transcription above 1-fold were considered upregulated in contrast with in vitro.

Evaluation of Immune Responses Between IVI Proteins and Adsorbed Serum

To evaluate the immune responses between IVI proteins and adsorbed serum, we selected 11 genes according to their functional category to express their products. The results of western blotting between the 11 IVI proteins and adsorbed chicken serum revealed that all there was only one specific band for 11 induced antigens (Fig. 4). There were specific immune responses between IVI proteins and chicken adsorbed serum.

Fig. 4.Western blotting for expression and reaction of IVI genes. Eleven IVI genes, including of 1-aspS (24-KD), 2-recG (24-KD), 3-gatA (24-KD), 4-Cj0190c (30-KD), 5-chuA (20-KD), 6-hemL (28-KD), 7-panC(20-KD), 8-cheA (14-KD), 9-Cj0160c (20-KD), 10-pheA (40-KD), and 11-Cj1481 (25-KD), were expressed in E. coli BL21(DE3). The responses of the chicken serum samples to these proteins were visualized by western blotting. There was only one specific band for 11 induced antigens with adsorbed chicken serum.

 

Discussion

C. jejuni is a major environmental microorganism and is ubiquitously found in hosts and media, including livestock and wild animals, and environmental water and soil [7]. Humans can be infected through the consumption of chicken products contaminated by C. jejuni. To control and eliminate campylobacteriosis, we must first understand the mechanisms of interaction between chicken and C. jejuni. In this study, IVIAT was employed to investigate the virulence-associated genes in vivo. IVIAT is a rigorous method that can identify virulence-associated antigens, which are expressed instantaneously in vivo when hosts are infected by pathogenic bacteria [29]. The sera of immunized chicken were collected and used for IVIAT. Before IVIAT, individual serum titers of chickens were determined by indirect ELISA. The higher titer sera were selected for adsorption. To thoroughly remove the antibodies in vitro, we adsorbed the pooled serum six times using various antigen preparations, such as those involving C. jejuni and DE3 (BL21) whole cells and lysates. In this study, an expression library was generated from 52,700 clones, equating to 4 times the size of the NCTC 11168 genome. We selected several genes, including chuA, flgS, and Cj0190c, through IVIAT that were found to have products that were upregulated in the C. jejuni F38011 strain in the presence of 0.1% sodium DOC. These culture conditions have been reported to mimic the in vivo environment [25].

Seven in vivo-induced genes classified with a metabolism function were identified in this study and may have important roles in bacterial growth or pathogenicity in vivo. Previous studies [14] have shown that some strains of C. jejuni can utilize glutamine or glutathione to enhance its ability to colonize the intestines of hosts. We discovered that hemL (involved in glutamine or glutathione and asparagine metabolism) is expressed during chicken and human infection with C. jejuni, indicating that these genes may be correlated with bacterial colonization. The gene fabH (Cj0328c) was upregulated (3.09-fold by microarray) during chicken colonization, indicating that the protein encoded by fabH may be an important virulence-associated factor in vivo [36].

Two genes, including hslV (Cj0663c) and Cj1200, were classified as having a molecular biosynthesis function. Seven in vivo-induced genes (rplA, rpmH, aspS, recG, gatA, ileS, and Cj1481c) were assigned to a genetic information processing function, but their specific functions have not been determined. All bacteria have DNA repair mechanisms, which act to reduce DNA damage and to maintain genetic structures and stability [8]. For C. jejuni, genomic polymorphisms are important for adaptation to diverse environments. However, DNA repair is essential for its survival in response to significant environmental stress. We hypothesize that these DNA repair genes containing nine in vivo-associated factors may be significant when C. jejuni lives in human or chicken tissues.

We identified three virulence-associated genes, chuA (Cj1614), corA (Cj0726c), and Cj1106, which were assigned to a transportation function. Gene chuA, which encodes the outer membrane uptake protein hemin [32], exhibited highly upregulated transcription in an in vitro microarray, indicating that chuA may be an essential factor for chicken colonization [36]. There are no reports on corA, which encodes for a magnesium and cobalt transport protein [3].

Six genes were obtained, and their products participate in regulation when chickens are infected with C. jejuni. One of the interesting invasion-associated genes [28], flgS (Cj0793), may encode a signal transduction histidine kinase in C. jejuni. Joslin and Hendrixson [2,20] proposed that the FlgS histidine kinase may receive a signal from the formation or activity of the flagellar T3SS, which activates FlgR for the expression of flagellar rod and hook genes. His141 of FlgS is essential for autophosphorylation and phosphorelay of FlgR. These molecular modifications are the basis for the regulation and motility of the FlgSR twocomponent regulatory system [20,37].

The gene cheA (Cj0284c), which encodes the chemotaxis protein CheA, is one of the fundamental components of the chemotaxis signaling pathway [13]. CheA plays a key role in chemotaxis by promoting CheY phosphorylation. The C. jejuni cheA mutants were nonchemotactic in vitro and showed defects in the colonization of a mouse model, suggesting a major function for CheA in chemotaxis in the presence of infection [22,38].

In short, IVIAT identified 28 C. jejuni NCTC 11168 genes expressed in vivo during interaction between chicken and C. jejuni. Several genes are closely correlated with the virulence and pathogenesis of C. jejuni, and these antigens may be candidates for vaccines.

References

  1. Ang CW, Dijkstra JR, de Klerk MA, Endtz HP, van Doorn PA, Jacobs BC, et al. 2010. Host factors determine anti-GM1 response following oral challenge of chickens with Guillain- Barre syndrome derived Campylobacter jejuni strain GB11. PLoS One 5: e9820. https://doi.org/10.1371/journal.pone.0009820
  2. Barrero-Tobon AM, Hendrixson DR. 2012. Identification and analysis of flagellar coexpressed determinants (Feds) of Campylobacter jejuni involved in colonization. Mol. Microbiol. 84: 352-369. https://doi.org/10.1111/j.1365-2958.2012.08027.x
  3. Cordwell SJ, Len AC, Touma RG, Scott NE, Falconer L, Jones D, et al. 2008. Identification of membrane-associated proteins from Campylobacter jejuni strains using complementary proteomics technologies. Proteomics 8: 122-139. https://doi.org/10.1002/pmic.200700561
  4. Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. 2010. Campylobacter jejuni: a brief overview on pathogenicityassociated factors and disease-mediating mechanisms. Int. J. Med. Microbiol. 300: 205-211. https://doi.org/10.1016/j.ijmm.2009.07.002
  5. Day CJ, Tiralongo J, Hartnell RD, Logue CA, Wilson JC, von Itzstein M, Korolik V. 2009. Differential carbohydrate recognition by Campylobacter jejuni strain 11168: influences of temperature and growth conditions. PLoS One 4: e4927. https://doi.org/10.1371/journal.pone.0004927
  6. Deb DK, Dahiya P, Srivastava KK, Srivastava R, Srivastava BS. 2002. Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach. Tuberculosis 82: 175-182. https://doi.org/10.1054/tube.2002.0337
  7. French N, Barrigas M, Brown P, Ribiero P, Williams N, Leatherbarrow H, et al. 2005. Spatial epidemiology and natural population structure of Campylobacter jejuni colonizing a farmland ecosystem. Environ. Microbiol. 7: 1116-1126. https://doi.org/10.1111/j.1462-2920.2005.00782.x
  8. Gaasbeek EJ, van der Wal FJ, van Putten JP, de Boer P, van der Graaf-van Bloois L, de Boer AG, et al. 2009. Functional characterization of excision repair and RecA-dependent recombinational DNA repair in Campylobacter jejuni. J. Bacteriol. 191: 3785-3793. https://doi.org/10.1128/JB.01817-08
  9. Gu H, Zhu H, Lu C. 2009. Use of in vivo-induced antigen technology (IVIAT) for the identification of Streptococcus suis serotype 2 in vivo-induced bacterial protein antigens. BMC Microbiol. 9: 201. https://doi.org/10.1186/1471-2180-9-201
  10. Handfield M, Brady LJ, Progulske-Fox A, Hillman JD. 2000. IVIAT: a novel method to identify microbial genes expressed specifically during human infections. Trends Microbiol. 8: 336-339. https://doi.org/10.1016/S0966-842X(00)01775-3
  11. Hang L, John M, Asaduzzaman M, Bridges EA, Vanderspurt C, Kirn TJ, et al. 2003. Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc. Natl. Acad. Sci. USA 100: 8508-8513. https://doi.org/10.1073/pnas.1431769100
  12. Harris JB, Baresch-Bernal A, Rollins SM, Alam A, LaRocque RC, Bikowski M, et al. 2006. Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect. Immun. 74: 5161- 5168. https://doi.org/10.1128/IAI.00488-06
  13. Hartley-Tassell LE, Shewell LK, Day CJ, Wilson JC, Sandhu R, Ketley JM, Korolik V. 2010. Identification and characterization of the aspartate chemosensory receptor of Campylobacter jejuni. Mol. Microbiol. 75: 710-730. https://doi.org/10.1111/j.1365-2958.2009.07010.x
  14. Hofreuter D, Novik V, Galan JE. 2008. Metabolic diversity in Campylobacter jejuni enhances specific tissue colonization. Cell Host Microbe 4: 425-433. https://doi.org/10.1016/j.chom.2008.10.002
  15. Hu Y, Cong Y, Li S, Rao X, Wang G, Hu F. 2009. Identification of in vivo induced protein antigens of Salmonella enterica serovar Typhi during human infection. Sci. China C Life Sci. 52: 942-948. https://doi.org/10.1007/s11427-009-0127-z
  16. Hu Y, Shang Y, Huang J, Wang Y, Ren F, Jiao Y, et al. 2013. A novel immunoproteomics method for identifying in vivoinduced Campylobacter jejuni antigens using pre-adsorbed sera from infected patients. BBA Gen. Subjects 1830: 5229- 5235. https://doi.org/10.1016/j.bbagen.2013.06.042
  17. Ibrahim GF, Fleet GH, Lyons MJ, Walker RA. 1985. Method for the isolation of highly purified Salmonella flagellins. J. Clin. Microbiol. 22: 1040-1044.
  18. Jeon B, Itoh K, Misawa N, Ryu S. 2003. Effects of quorum sensing on flaA transcription and autoagglutination in Campylobacter jejuni. Microbiol. Immunol. 47: 833-839. https://doi.org/10.1111/j.1348-0421.2003.tb03449.x
  19. John M, Kudva IT, Griffin RW, Dodson AW, McManus B, Krastins B, et al. 2005. Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection. Infect. Immun. 73: 2665-2679. https://doi.org/10.1128/IAI.73.5.2665-2679.2005
  20. Joslin SN, Hendrixson DR. 2009. Activation of the Campylobacter jejuni FlgSR two-component system is linked to the flagellar export apparatus. J. Bacteriol. 191: 2656-2667. https://doi.org/10.1128/JB.01689-08
  21. Leach S, Harvey P, Wali R. 1997. Changes with growth rate in the membrane lipid composition of and amino acid utilization by continuous cultures of Campylobacter jejuni. J. Appl. Microbiol. 82: 631-640. https://doi.org/10.1111/j.1365-2672.1997.tb02873.x
  22. Lertsethtakarn P, Ottemann KM, Hendrixson DR. 2011. Motility and chemotaxis in Campylobacter and Helicobacter. Annu. Rev. Microbiol. 65: 389-410. https://doi.org/10.1146/annurev-micro-090110-102908
  23. Li Q, Hu Y, Chen J, Liu Z, Han J, Sun L, Jiao X. 2013. Identification of Salmonella enterica serovar Pullorum antigenic determinants expressed in vivo. Infect. Immun. 81: 3119-3127. https://doi.org/10.1128/IAI.00145-13
  24. Lowry JE, Goodridge L, Vernati G, Fluegel AM, Edwards WH, Andrews GP. 2010. Identification of Brucella abortus genes in elk (Cervus elaphus) using in vivo-induced antigen technology (IVIAT) reveals novel markers of infection. Vet. Microbiol. 142: 367-372. https://doi.org/10.1016/j.vetmic.2009.10.010
  25. Malik-Kale P, Parker CT, Konkel ME. 2008. Culture of Campylobacter jejuni with sodium deoxycholate induces virulence gene expression. J. Bacteriol. 190: 2286-2297. https://doi.org/10.1128/JB.01736-07
  26. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, et al. 2000. The genome sequence of the foodborne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665-668. https://doi.org/10.1038/35001088
  27. Pearson B, Pin C, Wright J, I'Anson K, Humphrey T, Wells J. 2003. Comparative genome analysis of Campylobacter jejuni using whole genome DNA microarrays. FEBS Lett. 554: 224-230. https://doi.org/10.1016/S0014-5793(03)01164-5
  28. Poli VFS, Thorsen L, Olesen I, Wik MT, Jespersen L. 2012. Differentiation of the virulence potential of Campylobacter jejuni strains by use of gene transcription analysis and a Caco-2 assay. Int. J. Food Microbiol. 155: 60-68. https://doi.org/10.1016/j.ijfoodmicro.2012.01.019
  29. Rollins SM, Peppercorn A, Hang L, Hillman JD, Calderwood SB, Handfield M, Ryan ET. 2005. In vivo induced antigen technology (IVIAT). Cell Microbiol. 7: 1-9.
  30. Rollins SM, Peppercorn A, Young JS, Drysdale M, Baresch A, Bikowski MV, et al. 2008. Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis. PLoS One 3: e1824. https://doi.org/10.1371/journal.pone.0001824
  31. Salim KY, Cvitkovitch DG, Chang P, Bast DJ, Handfield M, Hillman JD, de Azavedo JC. 2005. Identification of group A Streptococcus antigenic determinants upregulated in vivo. Infect. Immun. 73: 6026-6038. https://doi.org/10.1128/IAI.73.9.6026-6038.2005
  32. Smith HK, Shepherd M, Monk C, Green J, Poole RK. 2011. The NO-responsive hemoglobins of Campylobacter jejuni: concerted responses of two globins to NO and evidence in vitro for globin regulation by the transcription factor NssR. Nitric Oxide 25: 234-241. https://doi.org/10.1016/j.niox.2010.12.009
  33. Sztajer H, Lemme A, Vilchez R, Schulz S, Geffers R, Ying Yin Yip C, et al. 2008. Autoinducer-2-regulated genes in Streptococcus mutans UA159 and global metabolic effect of the luxS mutation. J. Bacteriol. 190: 401-415. https://doi.org/10.1128/JB.01086-07
  34. Velayudhan J, Kelly D. 2002. Analysis of gluconeogenic and anaplerotic enzymes in Campylobacter jejuni: an essential role for phosphoenolpyruvate carboxykinase. Microbiology 148: 685-694. https://doi.org/10.1099/00221287-148-3-685
  35. Vucic S, Kiernan MC, Cornblath DR. 2009. Guillain-Barre syndrome: an update. J. Clin. Neurosci. 16: 733-741. https://doi.org/10.1016/j.jocn.2008.08.033
  36. Woodall CA, Jones MA, Barrow PA, Hinds J, Marsden GL, Kelly DJ, et al. 2005. Campylobacter jejuni gene expression in the chick cecum: evidence for adaptation to a low-oxygen environment. Infect. Immun. 73: 5278-5285. https://doi.org/10.1128/IAI.73.8.5278-5285.2005
  37. Wosten MM, Wagenaar JA, van Putten JP. 2004. The FlgS/ FlgR two-component signal transduction system regulates the fla regulon in Campylobacter jejuni. J. Biol. Chem. 279: 16214-16222. https://doi.org/10.1074/jbc.M400357200
  38. Xie L, Zhang S, Yao W. 2011. Construction of cheA insertion mutant of Campylobacter jejuni and the effect of its adhesion on mice jejunum. Acta Microbiologica Sinica 51: 208-213.
  39. Young K T, D av is LM, D irita VJ. 2007. Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5: 665-679. https://doi.org/10.1038/nrmicro1718
  40. Zhang H, Fan H, Lu C. 2010. Identification of a novel virulence-related gene in Streptococcus suis type 2 strains. Curr. Microbiol. 61: 494-499. https://doi.org/10.1007/s00284-010-9643-0
  41. Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M. 2008. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans. R. Soc. Trop. Med. Hyg. 102: 123-129. https://doi.org/10.1016/j.trstmh.2007.09.019
  42. Zou YX, Mo ZL, Hao B, Ye XH, Guo DS, Zhang PJ. 2010. Screening of genes expressed in vivo after infection by Vibrio anguillarum M3. Lett. Appl. Microbiol. 51: 564-569. https://doi.org/10.1111/j.1472-765X.2010.02935.x

Cited by

  1. Campylobacterin Poultry: Ecology and Potential Interventions vol.59, pp.2, 2015, https://doi.org/10.1637/11072-032315-review
  2. Cell Wall Anchoring of the Campylobacter Antigens to Lactococcus lactis vol.7, pp.None, 2016, https://doi.org/10.3389/fmicb.2016.00165
  3. cj0371 : A Novel Virulence-Associated Gene of Campylobacter jejuni vol.7, pp.None, 2014, https://doi.org/10.3389/fmicb.2016.01094
  4. RETRACTED ARTICLE: Campylobacter infections in poultry: update on challenges and potential immune interventions vol.72, pp.2, 2016, https://doi.org/10.1017/s0043933916000167
  5. Convergent Amino Acid Signatures in Polyphyletic Campylobacter jejuni Subpopulations Suggest Human Niche Tropism vol.10, pp.3, 2014, https://doi.org/10.1093/gbe/evy026
  6. Metal homeostasis in pathogenic Epsilonproteobacteria: mechanisms of acquisition, efflux, and regulation vol.13, pp.1, 2014, https://doi.org/10.1093/mtomcs/mfaa002